Incyte's Epacadostat Combo Trials With Merck’s Keytruda Reveals Promising Cancer Treatment Results Medicine & Technology Jun 06, 2017 Results from the trials combining Incyte’s epacadostat and Merck's Keytruda were revealed.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts